 |
29 Products |  |
56 Diseases | | 29 Products |
|
154 Trials |  |
7480 News |  |
| «12...7778798081828384858687...9899» |
- | cyclophosphamide / Generic mfg.
Trial completion date, Trial primary completion date, IO biomarker: A Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostate Cancer (clinicaltrials.gov) - Mar 14, 2018
P1/2, N=29, Active, not recruiting, Sponsor: Sidney Kimmel Comprehensive Cancer Center
Trial completion date: Apr 2018 --> May 2019 | Trial primary completion date: Apr 2018 --> Mar 2019
- ||||||| Hernicore (condoliase) / Seikagaku, Ferring
Trial completion: A Study of SI-6603 in Patients With Lumbar Disc Herniation (clinicaltrials.gov) - Mar 9, 2018
P3, N=360, Completed, Sponsor: Seikagaku Corporation
Trial completion date: Apr 2018 --> May 2019 | Trial primary completion date: Apr 2018 --> Mar 2019 Active, not recruiting --> Completed
- ||||||| Hernicore (condoliase) / Seikagaku, Ferring
Trial completion: A Study of SI-6603 in Patients With Lumbar Disc Herniation (clinicaltrials.gov) - Mar 9, 2018
P3, N=1000, Completed, Sponsor: Seikagaku Corporation
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||||| Cervidil (dinoprostone) / Ferring
Trial completion, Trial completion date, Trial primary completion date: An Open-label Trial Investigating the Efficacy and Safety of a Vaginal Insert in Pregnant Women at Term (clinicaltrials.gov) - Mar 8, 2018
P3, N=68, Completed, Sponsor: Ferring Pharmaceuticals
Active, not recruiting --> Completed Recruiting --> Completed | Trial completion date: Jun 2018 --> Feb 2018 | Trial primary completion date: Jun 2018 --> Feb 2018
- ||| Rekovelle (follitropin delta) / Ferring
Enrollment open, Trial initiation date: PROFILE: Study to Assess the Patterns of Use of REKOVELLE (clinicaltrials.gov) - Mar 5, 2018
P=N/A, N=1300, Recruiting, Sponsor: Ferring Pharmaceuticals
Recruiting --> Completed | Trial completion date: Jun 2018 --> Feb 2018 | Trial primary completion date: Jun 2018 --> Feb 2018 Not yet recruiting --> Recruiting | Initiation date: Mar 2018 --> Feb 2018
- |||| Cimzia (certolizumab pegol) / Astellas, UCB
Trial primary completion date: A Study to Test the Efficacy and Safety of Certolizumab Pegol in Japanese Subjects With Moderate to Severe Chronic Psoriasis (clinicaltrials.gov) - Mar 3, 2018
P2/3, N=149, Active, not recruiting, Sponsor: UCB Biopharma S.P.R.L.
Not yet recruiting --> Recruiting | Initiation date: Mar 2018 --> Feb 2018 Trial primary completion date: Dec 2018 --> Nov 2018
- || Menopur (menotropin) / Ferring
Trial primary completion date: A Study to Measure Relationship Between Antim (clinicaltrials.gov) - Mar 3, 2018
P=N/A, N=340, Recruiting, Sponsor: Ferring Pharmaceuticals
Trial primary completion date: Dec 2018 --> Nov 2018 Trial primary completion date: Dec 2017 --> Jan 2018
- || Rekovelle (follitropin delta) / Ferring
Trial initiation date: PROFILE: Study to Assess the Patterns of Use of REKOVELLE (clinicaltrials.gov) - Mar 3, 2018
P=N/A, N=1300, Not yet recruiting, Sponsor: Ferring Pharmaceuticals
Trial primary completion date: Dec 2017 --> Jan 2018 Initiation date: Jan 2018 --> Mar 2018
- || Zomacton (somatropin) / Ferring
Trial initiation date, Adherence: RAZANT: Study to Assess Long-term Effectiveness of Zomacton (clinicaltrials.gov) - Mar 3, 2018
P=N/A, N=700, Not yet recruiting, Sponsor: Ferring Pharmaceuticals
Initiation date: Jan 2018 --> Mar 2018 Initiation date: Feb 2018 --> Mar 2018
- | Climara (estradiol) / Bausch Health, Bayer, Firmagon (degarelix) / Astellas, Ferring
Trial initiation date: Effects of Ovarian Hormone Suppression on Vascular and Cognitive Function (clinicaltrials.gov) - Mar 3, 2018
P=N/A, N=30, Recruiting, Sponsor: University of Colorado, Denver
Initiation date: Feb 2018 --> Mar 2018 Initiation date: Jan 2018 --> Feb 2018
- | Actemra IV (tocilizumab) / Roche, JW Pharma
Biomarker, Trial completion date, Trial initiation date, Trial primary completion date: RAFTING: Rheumatoid Arthritis Treatment After First Anti-TNF INvestiGation (clinicaltrials.gov) - Mar 3, 2018
P4, N=400, Not yet recruiting, Sponsor: Mario Negri Institute for Pharmacological Research
Initiation date: Jan 2018 --> Feb 2018 Trial completion date: Sep 2021 --> Oct 2021 | Initiation date: Feb 2018 --> Mar 2018 | Trial primary completion date: Sep 2018 --> Oct 2018
- || Cimzia (certolizumab pegol) / Astellas, UCB
Trial completion date, Trial primary completion date: C-VIEW: A Study to Assess the Effects of Certolizumab Pegol on the Reduction of Anterior Uveitis (AU) Flares in Axial Spondyloarthritis Subjects With a Documented History of AU (clinicaltrials.gov) - Mar 3, 2018
P4, N=89, Active, not recruiting, Sponsor: UCB Biopharma S.P.R.L.
Trial completion date: Sep 2021 --> Oct 2021 | Initiation date: Feb 2018 --> Mar 2018 | Trial primary completion date: Sep 2018 --> Oct 2018 Trial completion date: Apr 2020 --> Mar 2020 | Trial primary completion date: Feb 2020 --> Jan 2020
- | Bravelle (urofollitropin) / Ferring
Trial completion date, Trial primary completion date: Pilot Study on the Effects of FSH Treatment on the Epigenetic Characteristics of Spermatozoa in Infertile Patients With Severe Oligozoospermia (clinicaltrials.gov) - Mar 3, 2018
P3, N=30, Terminated, Sponsor: Instituto de Investigacion Sanitaria La Fe
Trial completion date: Apr 2020 --> Mar 2020 | Trial primary completion date: Feb 2020 --> Jan 2020 Trial completion date: Jun 2017 --> Jun 2017 | Trial primary completion date: Jun 2017 --> Jun 2017
- ||| Pentasa (mesalamine) / Ferring, Takeda
Trial completion date: Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC) (clinicaltrials.gov) - Mar 3, 2018
P3, N=220, Active, not recruiting, Sponsor: Ferring Pharmaceuticals
Trial completion date: Jun 2017 --> Jun 2017 | Trial primary completion date: Jun 2017 --> Jun 2017 Trial completion date: Feb 2018 --> Apr 2018
- ||| Cimzia (certolizumab pegol) / Astellas, UCB
Trial completion date: CIMPACT: Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO) (clinicaltrials.gov) - Mar 3, 2018
P3, N=559, Active, not recruiting, Sponsor: UCB Biopharma S.P.R.L.
Trial completion date: Feb 2018 --> Apr 2018 Trial completion date: Dec 2018 --> Dec 2018
- | Menopur (menotropin) / Ferring, Orgalutran (ganirelix acetate) / Organon, Cetrotide (cetrorelix) / EMD Serono
Enrollment open, Trial initiation date: DuoStim in Cases of PGT: Comparison of Embryo Quantity and Embryonic Quality Using MitoScore (clinicaltrials.gov) - Feb 28, 2018
P=N/A, N=136, Recruiting, Sponsor: IVI Madrid
Trial completion date: Dec 2018 --> Dec 2018 Not yet recruiting --> Recruiting | Initiation date: Sep 2017 --> Dec 2017
- Firmagon (degarelix) / Astellas, Ferring
Trial completion date, Trial primary completion date, PARP Biomarker: Androgen Deprivation Therapy Prior to Prostatectomy for Patients with Intermediate and High Risk Prostate Cancer (clinicaltrials.gov) - Feb 26, 2018
P=N/A, N=41, Active, not recruiting, Sponsor: Memorial Sloan Kettering Cancer Center
Not yet recruiting --> Recruiting | Initiation date: Sep 2017 --> Dec 2017 Trial primary completion date: Feb 2018 --> Feb 2019 | Trial completion date: Feb 2018 --> Feb 2019
- Erleada (apalutamide) / J&J, Firmagon (degarelix) / Astellas, Ferring
Trial primary completion date: A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-prostatectomy (clinicaltrials.gov) - Feb 26, 2018
P2, N=22, Recruiting, Sponsor: University of Washington
Trial primary completion date: Feb 2018 --> Feb 2019 | Trial completion date: Feb 2018 --> Feb 2019 Trial primary completion date: Jul 2018 --> Jan 2019
- | Menopur (menotropin) / Ferring, Follistim AQ Cartridge (follitropin beta) / Organon, Bravelle (urofollitropin) / Ferring
Enrollment change: Maximal Stimulation and Delayed Fertilization for Diminished Ovarian Reserve: a Randomized Pilot Study (clinicaltrials.gov) - Feb 23, 2018
P4, N=23, Completed, Sponsor: Carolinas Healthcare System
Trial primary completion date: Jul 2018 --> Jan 2019 N=100 --> 23
- RBX7455 oral / Ferring
Trial primary completion date: Treatment of Recurrent Clostridium Difficile Infection With RBX7455 (clinicaltrials.gov) - Feb 22, 2018
P1, N=40, Recruiting, Sponsor: Mayo Clinic
N=100 --> 23 Trial primary completion date: Nov 2017 --> Nov 2018
- | Rebyota (fecal microbiota, live-jslm) / Ferring
New P1/2 trial: Fecal Transplant for Hepatic Encephalopathy (clinicaltrials.gov) - Feb 20, 2018
P1/2, N=30, Recruiting, Sponsor: University of Alberta
- | Cervidil (dinoprostone) / Ferring
Enrollment open, Trial initiation date: RUBAPRO: Cook Balloon Versus Propess After 12 Hours of Rupture of Membranes (clinicaltrials.gov) - Feb 19, 2018
P4, N=80, Recruiting, Sponsor: University Hospital, Clermont-Ferrand
Trial primary completion date: Nov 2017 --> Nov 2018 Not yet recruiting --> Recruiting | Initiation date: Nov 2017 --> Feb 2018
- | Menopur (menotropin) / Ferring, Orgalutran (ganirelix acetate) / Organon, Follistim AQ Cartridge (follitropin beta) / Organon
Trial completion, Trial primary completion date: Efficacy of Recombinant FSH/GnRH Antagonist Protocol With and Without LH Adjunct for Egg Bank Donation (clinicaltrials.gov) - Feb 13, 2018
P4, N=39, Completed, Sponsor: Michigan Reproductive Medicine
Not yet recruiting --> Recruiting | Initiation date: Nov 2017 --> Feb 2018 Recruiting --> Completed | Trial primary completion date: Apr 2018 --> Feb 2017
- ||||| Pentasa (mesalamine) / Ferring, Takeda
Enrollment closed, Trial primary completion date: Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC) (clinicaltrials.gov) - Feb 12, 2018
P3, N=220, Active, not recruiting, Sponsor: Ferring Pharmaceuticals
Recruiting --> Completed | Trial primary completion date: Apr 2018 --> Feb 2017 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2017 --> Feb 2018
- | Cervidil (dinoprostone) / Ferring
Trial completion date, Trial primary completion date: Efficacy and Safety of Hourly Titrated Misoprostol Versus Vaginal Dinoprostone and Misoprostol for Cervical Ripening and Labor Induction (clinicaltrials.gov) - Feb 12, 2018
P4, N=372, Recruiting, Sponsor: Oihane Lapuente Ocamica
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2017 --> Feb 2018 Trial primary completion date: Sep 2018 --> Sep 2020 | Trial completion date: Sep 2018 --> Sep 2020
- |||| Cimzia (certolizumab pegol) / Astellas, UCB
Trial completion date, Trial primary completion date: Pediatric Arthritis Study of Certolizumab Pegol (clinicaltrials.gov) - Feb 6, 2018
P3, N=163, Active, not recruiting, Sponsor: UCB BIOSCIENCES GmbH
Trial primary completion date: Sep 2018 --> Sep 2020 | Trial completion date: Sep 2018 --> Sep 2020 Trial primary completion date: Mar 2018 --> Feb 2019 | Trial completion date: May 2018 --> May 2019
- ||||| Lutrelef (gonadorelin acetate) / Ferring
Enrollment closed, Trial completion date, Trial primary completion date: LutrePulse Hypogonadotropic Hypogonadism (clinicaltrials.gov) - Feb 6, 2018
P3, N=60, Active, not recruiting, Sponsor: Ferring Pharmaceuticals
Trial primary completion date: Mar 2018 --> Feb 2019 | Trial completion date: May 2018 --> May 2019 Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2019 --> Feb 2018 | Trial completion date: Jun 2019 --> Feb 2018
- ||| Cimzia (certolizumab pegol) / Astellas, UCB
Enrollment closed, Trial initiation date: C-VIEW: A Study to Assess the Effects of Certolizumab Pegol on the Reduction of Anterior Uveitis (AU) Flares in Axial Spondyloarthritis Subjects With a Documented History of AU (clinicaltrials.gov) - Feb 6, 2018
P4, N=89, Active, not recruiting, Sponsor: UCB Biopharma S.P.R.L.
Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2019 --> Feb 2018 | Trial completion date: Jun 2019 --> Feb 2018 Recruiting --> Active, not recruiting | Initiation date: Jan 2017 --> Dec 2016
- | Remicade (infliximab) / J&J, Humira (adalimumab) / AbbVie, Cimzia (certolizumab pegol) / Astellas, UCB
Enrollment closed, Enrollment change, Trial completion date, Trial primary completion date: Impact of Medical Treatment on Sexual Function in Patients With Crohn's Disease (clinicaltrials.gov) - Feb 5, 2018
P=N/A, N=50, Active, not recruiting, Sponsor: University of Maryland
Recruiting --> Active, not recruiting | Initiation date: Jan 2017 --> Dec 2016 Recruiting --> Active, not recruiting | N=90 --> 50 | Trial primary completion date: Aug 2016 --> Jun 2018 | Trial completion date: Aug 2017 --> Jun 2018
- | Actemra IV (tocilizumab) / Roche, JW Pharma
Biomarker, Trial initiation date: RAFTING: Rheumatoid Arthritis Treatment After First Anti-TNF INvestiGation (clinicaltrials.gov) - Feb 5, 2018
P4, N=400, Not yet recruiting, Sponsor: Mario Negri Institute for Pharmacological Research
Recruiting --> Active, not recruiting | N=90 --> 50 | Trial primary completion date: Aug 2016 --> Jun 2018 | Trial completion date: Aug 2017 --> Jun 2018 Initiation date: Nov 2017 --> Feb 2018
- | Cervidil (dinoprostone) / Ferring
Trial completion, Trial initiation date, Trial primary completion date: Does Vaginal Washing Affect the Success Rate of the Labour Induction? (clinicaltrials.gov) - Jan 31, 2018
P=N/A, N=200, Completed, Sponsor: Zeynep Kamil Maternity and Pediatric Research and Training Hospital
Initiation date: Nov 2017 --> Feb 2018 Active, not recruiting --> Completed | Initiation date: Nov 2016 --> Feb 2017 | Trial primary completion date: Jun 2017 --> Dec 2017
- | Climara (estradiol) / Bausch Health, Bayer, Firmagon (degarelix) / Astellas, Ferring
Enrollment open: Effects of Ovarian Hormone Suppression on Vascular and Cognitive Function (clinicaltrials.gov) - Jan 24, 2018
P=N/A, N=30, Recruiting, Sponsor: University of Colorado, Denver
Active, not recruiting --> Completed | Initiation date: Nov 2016 --> Feb 2017 | Trial primary completion date: Jun 2017 --> Dec 2017 Not yet recruiting --> Recruiting
- | Euflexxa (hyaluronic acid) / Ferring
Trial completion, Enrollment change, Trial primary completion date: Effectiveness Trial for Evaluating IAHA for PFPS (clinicaltrials.gov) - Jan 23, 2018
P=N/A, N=30, Completed, Sponsor: New York University School of Medicine
Not yet recruiting --> Recruiting Active, not recruiting --> Completed | N=68 --> 30 | Trial primary completion date: Dec 2017 --> Dec 2016
- | Climara (estradiol) / Bausch Health, Bayer, Firmagon (degarelix) / Astellas, Ferring
Trial initiation date: Effects of Ovarian Hormone Suppression on Vascular and Cognitive Function (clinicaltrials.gov) - Jan 17, 2018
P=N/A, N=30, Not yet recruiting, Sponsor: University of Colorado, Denver
Active, not recruiting --> Completed | N=68 --> 30 | Trial primary completion date: Dec 2017 --> Dec 2016 Initiation date: Nov 2017 --> Feb 2018
- | Cervidil (dinoprostone) / Ferring
Enrollment change, Trial initiation date, Trial primary completion date: Combined Foley Catheter Balloon and PGE2 Vaginal Ovule for Induction of Labor at Term: A Randomized Study (clinicaltrials.gov) - Jan 16, 2018
P2, N=300, Completed, Sponsor: Zeynep Kamil Maternity and Pediatric Research and Training Hospital
Initiation date: Nov 2017 --> Feb 2018 N=200 --> 300 | Initiation date: Oct 2016 --> Aug 2017 | Trial primary completion date: Feb 2017 --> Dec 2017
- |||| Cervidil (dinoprostone) / Ferring
Trial primary completion date: An Open-label Trial Investigating the Efficacy and Safety of a Vaginal Insert in Pregnant Women at Term (clinicaltrials.gov) - Jan 12, 2018
P3, N=67, Recruiting, Sponsor: Ferring Pharmaceuticals
N=200 --> 300 | Initiation date: Oct 2016 --> Aug 2017 | Trial primary completion date: Feb 2017 --> Dec 2017 Trial primary completion date: Dec 2017 --> Jun 2018
- |||| Cervidil (dinoprostone) / Ferring
Trial primary completion date: A Randomised Trial Investigating the Efficacy and Safety of a Vaginal Insert in Pregnant Women at Term (clinicaltrials.gov) - Jan 12, 2018
P3, N=116, Recruiting, Sponsor: Ferring Pharmaceuticals
Trial primary completion date: Dec 2017 --> Jun 2018 Trial primary completion date: Dec 2017 --> Sep 2018
- | Firmagon (degarelix) / Astellas, Ferring
Enrollment open, Metastases: Pilot Trial of Chemohormonal Therapy Followed by Prostatectomy in High Risk Prostate Cancer (clinicaltrials.gov) - Jan 11, 2018
P1, N=30, Recruiting, Sponsor: University of Wisconsin, Madison
Trial primary completion date: Dec 2017 --> Sep 2018 Not yet recruiting --> Recruiting
- ||| Rekovelle (follitropin delta) / Ferring
New trial: PROFILE: Study to Assess the Patterns of Use of REKOVELLE (clinicaltrials.gov) - Jan 9, 2018
P=N/A, N=1300, Not yet recruiting, Sponsor: Ferring Pharmaceuticals
- | olamkicept (FE999301) / Ferring
Enrollment open, Trial primary completion date: Safety and Efficacy of TJ301 IV in Participants With Active Ulcerative Colitis (clinicaltrials.gov) - Jan 2, 2018
P2, N=90, Recruiting, Sponsor: Leading Biopharm Limited
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting | Trial primary completion date: Mar 2020 --> Jul 2019
- | Cervidil (dinoprostone) / Ferring
Enrollment change, Trial primary completion date: Combined Foley Catheter Balloon and PGE2 Vaginal Ovule for Induction of Labor at Term: A Randomized Study (clinicaltrials.gov) - Dec 26, 2017
P2, N=200, Completed, Sponsor: Zeynep Kamil Maternity and Pediatric Research and Training Hospital
Not yet recruiting --> Recruiting | Trial primary completion date: Mar 2020 --> Jul 2019 N=250 --> 200 | Trial primary completion date: Oct 2016 --> Feb 2017
- | Review, Journal: Management of psoriatic arthritis: Early diagnosis, monitoring of disease severity and cutting edge therapies. (Pubmed Central) - Dec 25, 2017
Herein we will review the mechanisms of action of these drugs, their results in clinical trials, and guidelines for administration. Lastly, treatment recommendations from the European League Against Rheumatism (EULAR) and The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) will be discussed.
- | Cimzia (certolizumab pegol) / Astellas, UCB
Trial completion: Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol (clinicaltrials.gov) - Dec 21, 2017
P2, N=16, Completed, Sponsor: UCB Pharma
Lastly, treatment recommendations from the European League Against Rheumatism (EULAR) and The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) will be discussed. Active, not recruiting --> Completed
- | Rebyota (fecal microbiota, live-jslm) / Ferring
Trial primary completion date: PediFETCh: Pediatric FEcal Microbiota Transplant for Ulcerative Colitis (clinicaltrials.gov) - Dec 19, 2017
P1, N=50, Recruiting, Sponsor: McMaster Children's Hospital
Active, not recruiting --> Completed Trial primary completion date: Dec 2017 --> Jul 2018
- | Glypressin (terlipressin) / Ferring
Trial completion, Trial initiation date, Trial primary completion date, Surgery: Effect of Terlipressin Infusion on Systemic and Hepatic Hemodynamics During Hepatobiliary Surgery (clinicaltrials.gov) - Dec 19, 2017
P2, N=50, Completed, Sponsor: Assiut University
Trial primary completion date: Dec 2017 --> Jul 2018 Recruiting --> Completed | Initiation date: Dec 2015 --> Apr 2016 | Trial primary completion date: Dec 2017 --> Jul 2017 | Recruiting --> Completed | Initiation date: Dec 2015 --> Apr 2016 | Trial primary completion date: Dec 2017 --> Jul 2017 | Recruiting --> Completed | Initiation date: Dec 2015 --> Apr 2016 | Trial primary completion date: Dec 2017 --> Jul 2017
- | RBX7455 oral / Ferring, Rebyota (fecal microbiota, live-jslm) / Ferring
New P1 trial: PediCRaFT: Pediatric Crohn's Disease Fecal Transplant Trial (clinicaltrials.gov) - Dec 18, 2017
P1, N=28, Not yet recruiting, Sponsor: McMaster Children's Hospital
- | Firmagon (degarelix) / Astellas, Ferring
Trial primary completion date: TRial on the Endocrine Activity of Neoadjuvant Degarelix (clinicaltrials.gov) - Dec 13, 2017
P2, N=51, Active, not recruiting, Sponsor: International Breast Cancer Study Group
Recruiting --> Completed | Initiation date: Dec 2015 --> Apr 2016 | Trial primary completion date: Dec 2017 --> Jul 2017 | Recruiting --> Completed | Initiation date: Dec 2015 --> Apr 2016 | Trial primary completion date: Dec 2017 --> Jul 2017 | Recruiting --> Completed | Initiation date: Dec 2015 --> Apr 2016 | Trial primary completion date: Dec 2017 --> Jul 2017 Trial primary completion date: Aug 2017 --> Mar 2018
- ||||| Rebyota (fecal microbiota, live-jslm) / Ferring
New P1/2 trial: Fecal Microbiota Transplantation (FMT) for MDRO UTI (clinicaltrials.gov) - Dec 11, 2017
P1/2, N=60, Not yet recruiting, Sponsor: Washington University School of Medicine
- | Xofigo (radium Ra-223 dichloride) / Bayer
New P2 trial, Combination therapy, Metastases: Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer (clinicaltrials.gov) - Dec 5, 2017
P2, N=24, Not yet recruiting, Sponsor: City of Hope Medical Center
- | Turalio (pexidartinib) / Daiichi Sankyo
Biomarker, Trial suspension, Tumor microenvironment: PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate Cancer (clinicaltrials.gov) - Dec 2, 2017
P1, N=24, Suspended, Sponsor: Barbara Ann Karmanos Cancer Institute
Trial primary completion date: Aug 2017 --> Mar 2018 Recruiting --> Suspended